Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (DR6.F) Q2 2023 Earnings
DR6.F
8
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.25
-0.22
-0.2
-0.17
Details
Expected EPS
-0.190932
Actual EPS
-0.245484
Surprise EPS
-0.05
Surprise Percent
+28.57%
Description
Acadia Pharmaceuticals (DR6.F) has reported earnings of -0.245484 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login